Although operational practices vary centre by centre, the routine use of the INTERCEPT™ Blood System for plasma has demonstrated significant operational gains that translate into savings.
- Plasma derived from an apheresis collection can be treated using a single INTERCEPT processing set, and results in three transfusion doses ready for use.
- Plasma derived from whole blood collections can be treated in an economical way thanks to the OptiPool™ methodology from Cerus.
Thanks to the OptiPool™ methodology from Cerus, plasma derived from whole blood collections can be treated in an economical way. The pooling of five plasma units with the DONOpack pooling kit produces six adult transfusion doses of inactivated plasma, using two INTERCEPT™ processing kits.
In comparison to single-unit pathogen inactivation processing, the combination of the INTERCEPT processing kit and the DONOpack pooling kit offers significant operational benefits.
In addition, the INTERCEPT UVA Illuminator is designed for high throughput processing: the device is space-efficient and stackable to minimise the footprint and maximise flexibility in lab design and layout.